Kalorama Information’s Post

VACUNAS. Efficacy of Six Different SARS-CoV-2 Vaccines during a six-month follow-up and five COVID-19 waves in Brazil and Mexico. Dr. David. #director #gerente #farma #industriafarmacéutica #industriafarmaceutica #vacunas #vaccines #covid #pharma #bigpharma

Meningococcal Vaccines Market is projected to grow at a CAGR of 6.32% by 2033 #Vaccines #TherapeuticDrugs > Download this new #Pharma report here > https://ow.ly/boq050Qmi2t

Meningococcal Vaccines Market is projected to grow at a CAGR of 6.32% by 2033 #Vaccines #TherapeuticDrugs > Download this new #Pharma report here > https://ow.ly/boq050Qmi2t

Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine, Vaxzevria, citing a surplus of newer vaccine options as the primary reason. The company has voluntarily withdrawn the "marketing authorization" for the vaccine within the European Union, and similar applications are expected to be made in other countries where the vaccine was approved. The decision comes amidst ongoing legal battles faced by AstraZeneca over allegations that its vaccine, developed in collaboration with the University of Oxford, led to fatalities and severe injuries, including Thrombosis with Thrombocytopenia Syndrome (TTS). #AstraZeneca #astrazenecanews #vaccinenews #WorldNews #pharmaceuticals #pharmaceuticalindustry #COVID19 #coronavirus #vaccine #VaccineSideEffects #withdrawal #TTS #trendingnews #viralnews #virals #healthandwellness

#Shingles #vaccine (Continued discussion): I prefer not to burden my patients with costly vaccines unless the #diseases are prevalent. I disagree with direct-to-consumer #advertising campaigns, particularly those promoting #expensive vaccines. However, I acknowledge the importance of selective vaccination for #immunosuppressed patients. Direct-to-consumer campaigns can instill a sense of urgency in patients, leading them to believe they need certain vaccines. This approach, also adopted by some other pharmaceutical companies for some drugs, can lead patients to prioritize expensive vaccines/drug over necessary medications (like #statins). This is not ideal.

The ripple effects of this withdrawal could be significant. Healthcare sectors will face immediate impacts, including shifts in vaccine supply chains and potential increases in cost as providers and governments transition to alternative vaccines. This will also influence investment in pharmaceutical R&D, potentially slowing down the innovation of new treatments. Moreover, the economic implications extend beyond healthcare. For eg, insurance industries might need to adjust their risk assessments and policies regarding vaccine coverage and compensation. There could also be impacts on global travel, especially if vaccine requirements shift, affecting tourism and business travel sectors. Overall, while the direct health implications are paramount, the indirect effects on global economic stability and sectoral operations will also merit close observation as the situation unfolds. #HealthcareIndustry #EconomicImpact #VaccineConfidence

Flu vaccines and Covid 19 vaccines can be administered at the same time. This is known as coadministration. 💉 Always be sure to consult your pharmacist for any questions or concerns you may have. #pharma #vaccine #pharmacy #fluvaccine #flu #canada #ocp #ontariopharmacy #pharmaceutics #pharmaceutical #covid #covid19 #covid19vacccine💉 #vaccines #ᴠaccinessavelives #seasonal #cold #sick #buyinggroup #independentpharmacy #independentpharmacyowner #independentpharmacies

UK-based pharmaceutical giant AstraZeneca is withdrawing its COVID-19 vaccine globally, days after acknowledging in court documents that it can cause a rare and dangerous side effect. The company had earlier accepted a connection between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS), a condition marked by unusually low levels of platelets combined with blood clot formation. However, calling the decision "purely coincidental," the pharma giant stated that the vaccine is being withdrawn due to a "surplus of available updated vaccines" since the pandemic. "As multiple variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines," the company said. AstraZeneca said that the surplus had led to a decline in demand for its vaccine, known as Vaxzevria since 2021, which is no longer being manufactured or supplied. According to a Telegraph report, The vaccine can no longer be used in the European Union after the company voluntarily withdrew its “marketing authorisation”. The report said the application to withdraw the vaccine was made on March 5 and came into effect on May 07, 2024. Similar withdrawal applications will be submitted in the UK and other countries. #vaccine #pharmaceuticals #pharma #india #covid19 #company #Indianstartupnews

The recent announcement by AstraZeneca, a pharmaceutical company based in the UK, to globally withdraw its COVID-19 vaccine due to reported side effects, has led to the Serum Institute of India revealing that it ceased production of Covishield in December 2021. The decision was made in response to a decrease in demand for the vaccine and the emergence of new variants. A spokesperson for the Serum Institute of India stated that with India achieving high vaccination rates in 2021 and 2022, along with the appearance of new mutant strains, the need for previous vaccines has significantly decreased. As a result, production and distribution of additional doses of Covishield have been halted since December 2021. Read more: https://lnkd.in/e6Ds2peJ Renuka Abraham Swarna Jain Himanshu Chandel Felina Das Swapna Singh Arnav Bose Priyal Jain Likhita Agrawal Manisha Arora Rahul Parekh Vinita Jagtiani Tanvi Shetty #healthcare #covid #Covishield #India #lifesciences #pharma

Did you know that prefilled syringes can potentially eliminate 40% of the manual drug preparation steps thereby making #drugdelivery much faster and safer for the patient? Connect with us to learn more: Russell (Bo) Kowalczyk, PJ Kim, or Morgan Amsler #vaccines #vaccination #pharma #pharmaceuticals #biotech #biotechnology #pharmaceuticalindustry #biotechnologyindustry